Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Barnich

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Journal of Crohn'S & Colitis|July 7, 2022
Phage Therapy Against Adherent-invasive E. coli: Towards a Promising Treatment of Crohn's Disease Patients?Delphine Boucher, Nicolas Barnich
Cellular and Molecular Gastroenterology and Hepatology|September 3, 2021
When Pathobiont-Carbohydrate Interaction Turns Bittersweet!Nicolas Barnich, Benoit Chassaing
Ebiomedicine|April 28, 2020
When Adherent-invasive E. coli plays with host glycosylation: Does it open new perspectives for therapeutic strategies in Crohn's disease?Jérémy Denizot, Nicolas Barnich
Virulence|December 24, 2010
Abnormal CEACAM6 expression in Crohn disease patients favors gut colonization and inflammation by adherent-invasive E. coliNicolas Barnich, Arlette Darfeuille-Michaud
World Journal of Gastroenterology|October 24, 2007
Role of bacteria in the etiopathogenesis of inflammatory bowel diseaseNicolas Barnich, Arlette Darfeuille-Michaud
Current Opinion in Gastroenterology|November 30, 2006
Adherent-invasive Escherichia coli and Crohn's diseaseNicolas Barnich, Arlette Darfeuille-Michaud
International Journal of Molecular Sciences|May 30, 2020
Adherent-Invasive <i>E. coli</i>: Update on the Lifestyle of a Troublemaker in Crohn's DiseaseMélissa Chervy, Nicolas Barnich, Jérémy Denizot
Self/Nonself|April 14, 2011
Immunopathogenesis of inflammatory bowel diseaseJulien Matricon, Nicolas Barnich, Denis Ardid
Nutrients|March 10, 2022
The Nutrition-Microbiota-Physical Activity Triad: An Inspiring New Concept for Health and Sports PerformanceNathalie Boisseau, Nicolas Barnich, Christelle Koechlin-Ramonatxo
Cancers|June 2, 2021
Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing <i>Escherichia coli</i> in Colorectal CancerJulie Veziant, Romain Villéger, Nicolas Barnich, et al.
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Journal of Crohn'S & Colitis|July 7, 2022
Phage Therapy Against Adherent-invasive E. coli: Towards a Promising Treatment of Crohn's Disease Patients?Delphine Boucher, Nicolas Barnich
Cellular and Molecular Gastroenterology and Hepatology|September 3, 2021
When Pathobiont-Carbohydrate Interaction Turns Bittersweet!Nicolas Barnich, Benoit Chassaing
Ebiomedicine|April 28, 2020
When Adherent-invasive E. coli plays with host glycosylation: Does it open new perspectives for therapeutic strategies in Crohn's disease?Jérémy Denizot, Nicolas Barnich
Virulence|December 24, 2010
Abnormal CEACAM6 expression in Crohn disease patients favors gut colonization and inflammation by adherent-invasive E. coliNicolas Barnich, Arlette Darfeuille-Michaud
World Journal of Gastroenterology|October 24, 2007
Role of bacteria in the etiopathogenesis of inflammatory bowel diseaseNicolas Barnich, Arlette Darfeuille-Michaud
Current Opinion in Gastroenterology|November 30, 2006
Adherent-invasive Escherichia coli and Crohn's diseaseNicolas Barnich, Arlette Darfeuille-Michaud
International Journal of Molecular Sciences|May 30, 2020
Adherent-Invasive <i>E. coli</i>: Update on the Lifestyle of a Troublemaker in Crohn's DiseaseMélissa Chervy, Nicolas Barnich, Jérémy Denizot
Self/Nonself|April 14, 2011
Immunopathogenesis of inflammatory bowel diseaseJulien Matricon, Nicolas Barnich, Denis Ardid
Nutrients|March 10, 2022
The Nutrition-Microbiota-Physical Activity Triad: An Inspiring New Concept for Health and Sports PerformanceNathalie Boisseau, Nicolas Barnich, Christelle Koechlin-Ramonatxo
Cancers|June 2, 2021
Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing <i>Escherichia coli</i> in Colorectal CancerJulie Veziant, Romain Villéger, Nicolas Barnich, et al.
Pageof 16